Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1905Neoplasms 1528Prostatic Neoplasms 751Colorectal Neoplasms 714Lung Neoplasms 582Motor Activity 391Head and Neck Neoplasms 328Colonic Neoplasms 311Uterine Cervical Neoplasms 297Pain 247Pancreatic Neoplasms 246Anxiety Disorders 220Rectal Neoplasms 213Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 193Stomach Neoplasms 191Polycystic Ovary Syndrome 188Ovarian Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Brain Neoplasms 168Urinary Bladder Neoplasms 165Depression 164Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 137Lymphoma 135Lymphoma, Follicular 128Obesity 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Completed × Erythema Multiforme × Clear all
NCT03044197 2019-06-05

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy

The University of Texas Medical Branch, Galveston

Phase NA Completed
24 enrolled 8 charts
Genitourinary

Erythema Multiforme, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡